Article info
PDFNeuromuscular
Review
Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis
- Correspondence to Dr Robert Steinbach, Department of Neurology, Jena University Hospital, Jena 07747, Thüringen, Germany; Robert.Steinbach{at}med.uni-jena.de
Citation
Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis
Publication history
- Received July 6, 2021
- Accepted November 29, 2021
- First published February 1, 2022.
Online issue publication
March 14, 2022
Article Versions
- Previous version (14 March 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.